Right-sided Colon Tumor, Laparoscopic Versus Open Surgery, in an ERAS Protocol
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01831245|
Recruitment Status : Completed
First Posted : April 15, 2013
Last Update Posted : February 20, 2015
Register study. Patients who had been operated for right-sided colon tumor or benign adenoids between year 2011 to 2012. The study compare open surgery with laparoscopic surgery in an ERAS (Enhanced Recovery After Surgery) protocol.
Operation of right-sided colon tumor and large benign adenoids, a better selection of patients for open or laparoscopic surgery can improve short term results.
|Condition or disease|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||125 participants|
|Target Follow-Up Duration:||2 Years|
|Official Title:||Right-sided Colon Tumor, Laparoscopic and Open Surgery, in an ERAS Protocol|
|Study Start Date :||January 2011|
|Actual Primary Completion Date :||July 2014|
|Actual Study Completion Date :||July 2014|
- Pathological Anatomic diagnosis (PAD) on a tumor biopsy [ Time Frame: day of surgery ]
After PAD result, malign or benign tumor, type of malign tumor,tumor growth, stage, lymphatic recharge.
Right selection of patients to laparoscopic versus open surgery in relation to PAD result?
- Length of hospital stay, days [ Time Frame: 30 days after surgery ]Compare laparoscopic versus open surgery
- C - reactive protein [ Time Frame: 1-7 days after surgery ]Inflammation answer laparoscopic versus open surgery
- Immobilizing patient after surgery [ Time Frame: 4 -10 hours after surgery ]After laparoscopic versus open surgery
- Leakage of anastomosis [ Time Frame: 0 - 30 days after surgery ]Compare laparoscopic versus open surgery
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01831245
|Stockholm, Sweden, 116 91|
|Stockholm, Sweden, 182 88|
|Örebro University Hospital|
|Örebro, Sweden, 701 85|
|Principal Investigator:||Ulf Gustafsson, MD, PhD||Karolinska Institutet|